IRIS Institutional Research Information System - OPENBS Open Archive UniBS

BORGHETTI, Paolo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.288
EU - Europa 1.563
AS - Asia 1.495
SA - Sud America 266
AF - Africa 31
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 6.655
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.240
SG - Singapore 543
CN - Cina 466
IT - Italia 420
DE - Germania 263
BR - Brasile 224
HK - Hong Kong 189
UA - Ucraina 179
PL - Polonia 146
FI - Finlandia 120
GB - Regno Unito 90
VN - Vietnam 84
RU - Federazione Russa 77
TR - Turchia 73
FR - Francia 58
IE - Irlanda 53
NL - Olanda 45
IN - India 34
CA - Canada 30
CZ - Repubblica Ceca 26
BD - Bangladesh 24
AR - Argentina 18
ID - Indonesia 18
MX - Messico 14
SE - Svezia 14
ES - Italia 13
ZA - Sudafrica 13
JP - Giappone 11
AT - Austria 8
LT - Lituania 8
PK - Pakistan 8
BE - Belgio 7
EU - Europa 6
IQ - Iraq 6
AL - Albania 5
CO - Colombia 5
EC - Ecuador 5
IL - Israele 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
BY - Bielorussia 4
GR - Grecia 4
MA - Marocco 4
MK - Macedonia 4
SA - Arabia Saudita 4
UG - Uganda 4
UZ - Uzbekistan 4
PE - Perù 3
AM - Armenia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
DK - Danimarca 2
EG - Egitto 2
ET - Etiopia 2
HU - Ungheria 2
IR - Iran 2
IS - Islanda 2
JO - Giordania 2
KG - Kirghizistan 2
KR - Corea 2
KZ - Kazakistan 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
AO - Angola 1
BB - Barbados 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GY - Guiana 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
NR - Nauru 1
PH - Filippine 1
PY - Paraguay 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.655
Salva come PNG Salva come JPEG
Città #
Ashburn 410
Fairfield 315
Singapore 270
Chandler 198
Hong Kong 187
Woodbridge 180
Houston 175
Seattle 160
Warsaw 141
Jacksonville 137
New York 128
Cambridge 126
Wilmington 114
Beijing 113
Dearborn 93
Helsinki 87
Los Angeles 86
Munich 86
Princeton 84
Ann Arbor 63
Dallas 62
Istanbul 53
Brescia 51
Dublin 50
Milan 40
Des Moines 39
Nanjing 39
Shanghai 34
Ho Chi Minh City 30
The Dalles 30
São Paulo 28
Moscow 26
Dong Ket 24
San Diego 24
Redondo Beach 23
Washington 21
Buffalo 20
London 20
San Francisco 20
Turku 20
Boardman 18
Denver 18
Brno 16
Brooklyn 16
Santa Clara 16
Changsha 15
Nanchang 15
Chennai 13
Chicago 13
Atlanta 12
Hanoi 12
Jakarta 12
Hebei 11
Montreal 11
Orem 11
Poplar 11
Shenyang 11
Tokyo 11
Jinan 10
Johannesburg 10
Rome 10
Frankfurt am Main 9
Kunming 9
Tianjin 9
Zhengzhou 9
Ankara 8
Düsseldorf 8
Florence 8
Nuremberg 8
Romola 8
Toronto 8
Rio de Janeiro 7
Amsterdam 6
Bologna 6
Boston 6
Brasília 6
Brussels 6
Campinas 6
Guangzhou 6
Lancaster 6
Manchester 6
Paris 6
Phoenix 6
Stockholm 6
Charlotte 5
Cleveland 5
Haikou 5
Jiaxing 5
Kocaeli 5
Mexico City 5
Newark 5
Ningbo 5
Olomouc 5
Ribeirão Preto 5
Roubaix 5
Tirana 5
Verona 5
Augusta 4
Bari 4
Belo Horizonte 4
Totale 4.319
Salva come PNG Salva come JPEG
Nome #
Correction to: Tocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial 395
Light and shadows of a new technique: Isphoton total-skin irradiation using helical IMRT feasible, less complex and as toxic as the electrons one? 238
Resected pN1 non-small cell lung cancer: recurrence patterns and nodal risk factors may suggest selection criteria for post-operative radiotherapy 206
Efficacy of stereotactic body radiotherapy in oligorecurrent and in oligoprogressive prostate cancer: new evidence from a multicentric study 206
From chemotherapy to target therapies associated with radiation in the treatment of NSCLC: a durable marriage? 195
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 187
Mebendazole as a candidate for drug repurposing in oncology: An extensive review of current literature 171
The treatment of patients with 1-3 brain metastases: is there a place for whole brain radiotherapy alone, yet? A retrospective analysis 168
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 165
Oligometastatic prostate cancer patients stratification: A molecular signature identified by liquid biopsy 160
Primary cutaneous non-Hodgkin lymphoma: results of a retrospective analysis in the light of the recent ILROG guidelines 158
Pattern of relapse of glioblastoma multiforme treated with radical radio-chemotherapy: Could a margin reduction be proposed? 156
Salvage Low Dose Rate Brachytherapy For Recurrent Prostate Cancer After External Beam Radiotherapy: Results From A Single Institution With Focus On Toxicity And Functional Outcomes 156
Hypofractionated radiation therapy versus chemotherapy with temozolomide in patients affected by RPA class V and VI glioblastoma: a randomized phase II trial 154
Radiotherapy for adult medulloblastoma: Long term result from a single institution. A review of prognostic factors and why we do need a multi-institutional cooperative program 149
Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique 149
Differential Diagnosis and Clinical Management of a Case of COVID-19 in a Patient With Stage III Lung Cancer Treated With Radio-chemotherapy and Durvalumab 146
Postoperative radiotherapy for prostate cancer: the sooner the better and potential to reduce toxicity even further 145
From Molecular to Clinical Radiation Biology of Glioblastoma 142
Exploring the role of enzalutamide in combination with radiation therapy: An in vitro study 142
Radiotherapy and Tyrosine Kinase Inhibitors in Stage IV Non-small Cell Lung Cancer: Real-life Experience 133
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 133
Three-dimensional conformal radiotherapy, static intensity-modulated and helical intensity-modulated radiotherapy in glioblastoma. Dosimetric comparison in patients with overlap between target volumes and organs at risk. 132
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study 126
Stereotactic Radiation Therapy of Lung Cancers and Subsequent Parenchymal Alterations: from Their Spatial Distribution to the Use in Clinical Practice 126
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent 122
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 117
Current radiotherapy techniques in NSCLC: challenges and potential solutions 117
Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group 112
Treatment paths for localised prostate cancer in Italy: The results of a multidisciplinary, observational, prospective study (Pros-IT CNR) 100
A Systematic Review on Intensity Modulated Radiation Therapy for Mediastinal Hodgkin's Lymphoma 100
Changes in body composition and lipid profile in prostate cancer patients without bone metastases given Degarelix treatment: the BLADE prospective cohort study 98
Radiotherapy for the treatment of solitary plasmacytoma: 7-year outcomes by a mono-institutional experience 97
The “Radioresistance” of Glioblastoma in the Clinical Setting, and the Present Therapeutic Options 96
A multicenter LArge retrospectIve daTabase on the personalization of stereotactic ABlative radiotherapy use in lung metastases from colon-rectal cancer: The LaIT-SABR study 91
RR Myelo POINT: A Retrospective Single-Center Study Assessing the Role of Radiotherapy in the Management of Multiple Myeloma and Possible Interactions with Concurrent Systemic Treatment 90
Health-related quality of life 24-month after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study 85
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 82
Prevention and management of acute esophageal toxicity during concomitant chemoradiotherapy for locally advanced lung cancer 82
Letter to the Editor 81
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 80
The potential role of SPECT/CT in the clinical management of COVID-19 lung cancer patients undergoing radiotherapy 79
'Le Roi est mort, vive le Roi': New Roles of Radiotherapy in the Treatment of Lymphomas in Combination With Immunotherapy 76
Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience 75
The role of postoperative radiotherapy for thymomas: a multicentric retrospective evaluation from three Italian centers and review of the literature 65
Sterotactic Ablative Radiotherapy in a Multicentric Series of Oligometastatic SCLC: The SAMOS Cohort 64
Concomitant radiotherapy and TKI in metastatic EGFR- or ALK-mutated non-small cell lung cancer: a multicentric analysis on behalf of AIRO lung cancer study group 63
Universal testing for COVID-19 in patients undergoing cancer treatment during the second outbreak in Brescia 60
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study 60
High dose proton and photon-based radiation therapy for 213 liver lesions: a multi-institutional dosimetric comparison with a clinical perspective 57
Unmet needs in the management of unresectable stage III non-small cell lung cancer: a review after the 'radio talk' webinars 54
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 54
Unresectable stage III non-small cell lung cancer: could durvalumab be safe and effective in real-life clinical scenarios? Results of a single-center experience 52
The role of stereotactic body radiation therapy and its integration with systemic therapies in metastatic kidney cancer: a multicenter study on behalf of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) genitourinary study group 49
Artificial Intelligence-suggested Predictive Model of Survival in Patients Treated With Stereotactic Radiotherapy for Early Lung Cancer 47
Stereotactic body radiotherapy for spinal oligometastases: a survey on patterns of practice on behalf of the Italian Association of Clinical Oncology and Radiotherapy (AIRO) 41
Oligometastatic Mesothelioma Treated with Ablative Radiotherapy (OMAR): A Multicenter Study 36
What Have You Been Told? Awareness of Prognosis of Patients in an Italian Home Palliative Care Service 29
Management of patients with extensive small-cell lung cancer in the immunotherapy era: An Italian consensus through a Delphi approach 26
null 13
Totale 6.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.547
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.547
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021503 0 0 0 0 0 82 48 73 72 106 60 62
2021/2022437 35 38 10 13 27 31 26 34 27 47 24 125
2022/2023514 55 18 24 36 51 105 5 69 96 6 31 18
2023/2024775 29 16 94 45 45 179 35 47 102 41 36 106
2024/20251.337 28 40 26 195 100 139 89 73 147 119 234 147
2025/20261.509 265 284 196 398 330 36 0 0 0 0 0 0
Totale 6.788